Scientists pinpoint driver of IBD and other disorders with work under way to adapt existing drugs to treat patients
Researchers have discovered a major driver of inflammatory bowel disease (IBD) and several other immune disorders that affect the spine, liver and arteries, raising hopes for millions of people worldwide who experience these conditions.
The breakthrough is particularly exciting because the newly found biological pathway can be targeted by drugs that are already used, with work under way to adapt them to patients with IBD and other conditions.
About Author
More Stories
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
Researchers create AI-based tool that restores age-damaged artworks in hours
European journalists targeted with Paragon Solutions spyware, say researchers